Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 1/20 | 0.38 |
| ▸ | AHR | P35869 | 7/20 | 0.37 |
| ▸ | TLR9 | Q9NR96 | 3/20 | 0.32 |
| ▸ | TLR8 | Q9NR97 | 3/20 | 0.32 |
| ▸ | TLR7 | Q9NYK1 | 3/20 | 0.32 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.32 |
| ▸ | COMT | P21964 | 1/20 | 0.32 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.32 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.31 |
| ▸ | JAK2 | O60674 | 1/20 | 0.31 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.31 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.31 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.31 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7921087 | 0.79 | AHR (0.46) | DYRK1AAHRTLR9TLR8TLR7 | |
| SCHEMBL5930721 | 0.76 | DYRK1A (0.38) | DYRK1AAHRTLR9TLR8TLR7 | |
| SCHEMBL22438963 | 0.76 | DYRK1A (0.38) | DYRK1AAHRTLR9TLR8TLR7 | |
| SCHEMBL618586 | 0.76 | AHR (0.60) | DYRK1AAHRTGFBR1PIK3CG | |
| SCHEMBL10271997 | 0.76 | AHR (0.51) | DYRK1AAHRPIK3CD | |
| Hydrochloric Acid SCHEMBL31600019 | 0.74 | DYRK1A (0.37) | DYRK1AAHRTLR9TLR8TLR7 | |
| SCHEMBL15294468 | 0.73 | DYRK1A (0.36) | DYRK1AAHRTGFBR1HSD11B1 | |
| SCHEMBL18611836 | 0.73 | TLR8 (0.37) | DYRK1AAHRTLR9TLR8TLR7 | |
| SCHEMBL21646518 | 0.73 | DYRK1A (0.36) | DYRK1AAHRTLR9TLR8TLR7 | |
| SCHEMBL16808003 | 0.73 | RAB9A (0.40) | DYRK1AAHRTLR9TLR8TLR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110098471-A1 | OXAZOLIDINONE DERIVATIVE HAVING FUSED RING | RESEARCH FOUNDATION ITSUU LABORATORY (JP) | 2011-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110098471-A1 | OXAZOLIDINONE DERIVATIVE HAVING FUSED RING | OXER1, ALOX12, CYP1A1 | DYRK1A 1502/4885AHR 20/4885TLR9 2478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.